cyproterone acetate has been researched along with Diabetes Mellitus, Type 2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Zegher, F; Díaz, M; Ibáñez, L | 1 |
| Borisova, AM; Dakovska, L; Genov, N; Kamenova, P; Kirilov, G; Koev, D; Kovacheva, R; Milcheva, B; Tankova, Ts | 1 |
| Azem, F; Bar-Am, A; Grisaru, D; Inbar, M; Lessing, JB; Oren, M | 1 |
| Borissova, AM; Dakovska, L; Genov, N; Kamenova, P; Kirilov, G; Koev, D; Kovacheva, R; Milcheva, B; Tankova, T | 1 |
1 trial(s) available for cyproterone acetate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Circulating follistatin concentrations in adolescent PCOS: Divergent effects of randomized treatments.
Topics: Adolescent; Cyproterone Acetate; Diabetes Mellitus, Type 2; Female; Follistatin; Humans; Hypoglycemic Agents; Insulin; Metformin; Pioglitazone; Polycystic Ovary Syndrome | 2023 |
3 other study(ies) available for cyproterone acetate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Cyproterone acetate improves beta-cell function in postmenopausal women with diabetes mellitus type 2].
Topics: Blood Glucose; Bone Density; Cyproterone Acetate; Diabetes Mellitus, Type 2; Estrogen Replacement Therapy; Female; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Middle Aged; Postmenopause | 2003 |
A case of severe hyperandrogenism, acanthosis nigricans and over diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management.
Topics: Acanthosis Nigricans; Adult; Amenorrhea; Cyproterone Acetate; Diabetes Mellitus, Type 2; Female; Hirsutism; Humans; Hyperandrogenism; Magnetic Resonance Imaging; Ovary; Polycystic Ovary Syndrome; Testosterone; Ultrasonography | 1996 |
Effect of hormone replacement therapy on insulin secretion and insulin sensitivity in postmenopausal diabetic women.
Topics: Administration, Cutaneous; Antioxidants; Body Mass Index; Cyproterone Acetate; Diabetes Mellitus, Type 2; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Fasting; Female; Glucose Clamp Technique; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Insulin Secretion; Middle Aged; Oxidative Stress; Postmenopause; Superoxide Dismutase | 2002 |